BioInformant

Your Global Leader in Stem Cell Market Research

Home » Stem Cells » Adipose SCs

AASCP To Host Free Virtual Congress and FDA Safety Panel on November 7-8, 2020

By Leave a Comment

On November 7-8, 2020, the American Academy of Stem Cell Physicians (AASCP) is hosting a Free Scientific Congress and Safety Panel with FDA participation.

Stem cells applications are expanding at an accelerating rate, with a search of the world’s largest clinical trial database (ClinicalTrials.gov) revealing that at least 7,994 trials now involve stem cell products or their derivatives. As the world’s largest database of clinical trials, this figure likely contains approximately three-quarters of clinical trials worldwide ― making the total count even higher.

In addition to stem cell products, a growing market has evolved for a diverse range of regenerative medicine products, including cellular therapies, immunotherapies, exosome therapies, biomaterials, tissue engineered products (TEPs), biologics, and more. [Read more…]

Stem Cell Treatments For COPD in 2020

By Leave a Comment

A diagnosis of chronic obstructive pulmonary disease (COPD) can be alarming, but thanks to stem cell treatments for COPD, the situation may not be dire. Once a patient develops COPD, it means that he or she has developed complications to existing breathing problems. The chronic disease happens when inflammation in the lung interferes with airflow.

Not being able to breathe properly and having frequent chest tightness can be distressing, especially when it is caused by a chronic disease, rather than a temporary illness like bronchitis. Thankfully, new options for treatment emerge every day. Among these options are stem cell treatments for COPD. [Read more…]

Diversifying Cord Blood Banking through Adipose-Derived Stem Cell Storage

By 1 Comment

The global cord blood banking industry has been rapidly maturing in recent years. In part, this has been caused by changes in processing, storage, and transplantation technologies. These changes require executives and industry decision-makers to have a firm understanding of emerging trends.

One of the most notable cord blood industry trends has been a diversification of services. Put simply, cord blood banks are becoming diversified stem cell biobanks. [Read more…]

Celltex Therapeutics Receives Another FDA Approval: Phase II Clinical Trial Using MSCs a Prophylactic Against COVID-19

By Leave a Comment

June 26, 2020, HOUSTON — Celltex, a Houston, Texas-based biotechnology company, announced that it has received approval from the U.S. Food and Drug Administration (FDA) to proceed with the Company’s Investigational New Drug application (IND 22055) to investigate the Prophylactic Efficacy of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) Against Coronavirus Disease 2019 (COVID-19). [Read more…]

American Academy of Stem Cell Physicians To Host 1st Virtual Congress & Safety Panel (August 1-2, 2020)

By Leave a Comment

While COVID-19 has caused many events to be rescheduled, a highly anticipated and sought after American Academy of Stem Cell Physicians (AASCP) meeting is back by popular demand. Over August 1-2, 2020, the AASCP will host its first virtual congress, allowing for wide-scale participation at an unprecedented scale. The Academy is expecting 5,000 attendees, as the program will be broadcasting internationally.
 [Read more…]

BioInformant's World-Class Clients